FIELD: medicine; pharmacology. ^ SUBSTANCE: are offered application of Safinamid from 0.5 to 1,2,3,4 or 5 mg/kg/day, in a combination with levodopa/PDI (peripheral antioxidant of decarboxylase: levodopa plus carbidopa (SINEMET(R)), levodopa plus carbidopa of controlled release (SINEMET-CR(R)), levodopa plus benserazide (MADOPAR(R)), levodopa plus benserazide of controlled release (MADOPAR-HBS) for treatment of Parkinson's disease, the corresponding set and the pharmaceutical composition. ^ EFFECT: additional effect of increase in frequency of revealing of the patients reacting to treatment with dopamine agonist. ^ 8 cl, 2 tbl
METHODS OF PARKINSON'S DISEASE TREATMENT